Mechanical circulatory support for heart failure: Past, present and a look at the future

被引：0
作者：
机构：
[1] Department of Thoracic and Cardiovascular Surgery, Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland
[2] Kaufman Center for Heart Failure, Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland
[3] Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland
来源：
Moazami, N. (moazamn@ccf.org) | 2013年 / Expert Reviews Ltd.卷 / 10期
关键词：
circulation; heart; heart failure; heart transplantation; heart-assist devices; pumps;
D O I：
10.1586/erd.12.69
中图分类号：
学科分类号：
摘要：
Heart transplantation remains the gold standard for long-term cardiac replacement, but a shortage of donor organs will always limit this option. For both transplant-eligible and noneligible patients, advances in mechanical circulatory support have revolutionized the options for the management of end-stage heart failure, and this technology continues to bring us closer to a true alternative to heart transplantation. This review provides a perspective on the past, present and future of mechanical circulatory support and addresses the changes in technology, patient selection and management strategies needed to have this therapy fully embraced by the heart failure community, and perhaps replace heart transplantation either as the therapy of choice or as a strategy by which to delay transplantation in younger patients. © 2013 Expert Reviews Ltd.
引用
收藏
页码：55 / 71
页数：16
相关论文
共 83 条
[1]  
Copeland J.G., Smith R.G., Arabia F.A., Nolan P.E., Sethi G.K., Tsau P.H., McClellan D., Slepian M.J., Cardiac replacement with a total artificial heart as a bridge to transplantation, New England Journal of Medicine, 351, 9, pp. 859-867, (2004)
[2]  
Smedira N.G., Hoercher K.J., Yoon D.Y., Et al., Bridge to transplant experience: Factors influencing survival to and after cardiac transplant, J. Thorac. Cardiovasc. Surg., 139, 5, pp. 1295-1305, (2010)
[3]  
Nativi J.N., Drakos S.G., Kucheryavaya A.Y., Et al., Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: An analysis of the registry of the International Society for Heart and Lung Transplantation, J. Heart Lung Transplant., 30, 8, pp. 854-861, (2011)
[4]  
Navia J.L., McCarthy P.M., Hoercher K.J., Et al., Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation?, Ann Thorac. Surg., 74, 6, pp. 2051-2062, (2002)
[5]  
Cleveland Jr. J.C., Grover F.L., Fullerton D.A., Et al., Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival, J. Thorac. Cardiovasc. Surg., 136, 3, pp. 774-777, (2008)
[6]  
Rose E.A., Gelijns A.C., Moskowitz A.J., Et al., Long-term use of a left ventricular assist device for end-stage heart failure, N. Engl. J. Med., 345, 20, pp. 1435-1443, (2001)
[7]  
Kirklin J.K., Naftel D.C., Pagani F.D., Et al., Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?, J Thorac. Cardiovasc. Surg., 144, 3, pp. 584-603, (2012)
[8]  
Sheikh F.H., Russell S.D., HeartMate® II continuous-flow left ventricular assist system, Expert Rev. Med. Devices, 8, 1, pp. 11-21, (2011)
[9]  
Krishnamani R., DeNofrio D., Konstam M.A., Emerging ventricular assist devices for long-term cardiac support, Nat. Rev. Cardiol., 7, 2, pp. 71-76, (2010)
[10]  
Letsou G.V., Myers T.J., Gregoric I.D., Delgado R., Shah N., Robertson K., Radovancevic B., Frazier O.H., Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months, Annals of Thoracic Surgery, 76, 4, pp. 1167-1170, (2003)
123456789